Traditional diode transscleral cyclophotocoagulation has been deeply ingrained as a procedure intended for patients with severe end-stage glaucoma and poor vision. However, I have become increasingly ...

In the treatment of glaucoma, the ability of continuous-wave (CW) transscleral laser photocoagulation (TSCPC) to lower intraocular pressure (IOP) must be weighed against its established risks.

IRIDEX Corp. has announced the launch of a new glaucoma procedure based on its MicroPulse technology, according to a news release. The non-invasive, in-office glaucoma therapy, a tissue-sparing, ...

MOUNTAIN VIEW, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...

The aim of this study was to investigate the safety and efficacy of using MicroPulse laser trabeculoplasty (MLT), first developed by IRIDEX (Mountain View, California), in the treatment of open-angle ...

Please provide your email address to receive an email when new articles are posted on . A study investigated subthreshold MicroPulse laser therapy for center-involved diabetic macular edema. The ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

MOUNTAIN VIEW, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...

MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced that in the second quarter of 2018 it has shipped the 1,000th unit of its Cyclo G6™ Laser ...